China developed its first batch of A/H1N1 flu vaccines.
Experts say the vaccine must first undergo preliminary tests for safety and effectiveness before clinical tests in July. The vaccine is expected to go on the market in September. Experts say the vaccine is targeted at groups who have chronic diseases or are otherwise vulnerable, to minimize fatalities. It is not intended for general public use.
